The chipmaker's shares hit new records on lots of good news, and there's plenty to be excited about for the future.
Kimberly-Clark agrees to buy Tylenol maker Kenvue in a cash-and-stock deal valued at about $48.7 billion, including debt.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback